Kathleen M. Cronin is Sr MD Gen Counsel & Corp Secr at CME GROUP INC. (CME). They have made 15 open-market trades across 1 company since 2006, most recently 2023-05-03.
CIK 0001259107
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CME | SELL | 2022-03-11 | 2022-03-14 | $227.15 | $909K | +6.0% | +3.5% | -12.2% |
| CME | SELL | 2021-06-14 | 2021-06-16 | $215.31 | $1.8M | -1.7% | -4.4% | -13.8% |
| CME | SELL | 2020-12-14 | 2020-12-15 | $178.41 | $2.2M | -0.6% | +7.0% | +15.2% |
| CME | SELL | 2019-12-13 | 2019-12-16 | $204.12 | $1.4M | -0.5% | +0.6% | -27.1% |
| CME | SELL | 2019-05-21 | 2019-05-22 | $186.69 | $1.9M | +5.4% | +6.7% | +15.6% |
| CME | SELL | 2019-03-14 | 2019-03-18 | $167.50 | $2.6M | -4.2% | +4.1% | +14.6% |
| CME | SELL | 2018-05-31 | 2018-06-01 | $164.75 | $876K | +1.7% | -2.2% | +3.4% |
| CME | SELL | 2017-06-14 | 2017-06-15 | $127.35 | $1.9M | -1.5% | -4.7% | +3.4% |
| CME | SELL | 2017-03-14 | 2017-03-15 | $124.26 | $733K | -5.4% | -6.0% | +0.9% |
| CME | SELL | 2016-06-06 | 2016-06-07 | $96.84 | $600K | -1.2% | +3.0% | +13.1% |
| CME | SELL · 10b5-1 | 2015-06-12 | 2015-06-15 | $98.44 | $640K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2015-06-03 | 2015-06-04 | $95.00 | $190K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2014-11-03 | 2014-11-04 | $84.52 | $162K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2013-12-10 | 2013-12-12 | $80.18 | $93K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2013-06-12 | 2013-06-13 | $72.66 | $228K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2012-09-13 | 2012-09-17 | $59.42 | $155K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $292.91 | $146K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2010-08-02 | 2010-08-03 | $281.97 | $52K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2010-04-15 | 2010-04-19 | $319.16 | $428K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2010-03-31 | 2010-03-31 | $313.95 | $157K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2010-01-14 | 2010-01-19 | $342.00 | $205K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2009-06-12 | 2009-06-16 | $337.40 | $375K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2007-10-15 | 2007-10-17 | $629.00 | $289K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2007-08-15 | 2007-08-16 | $562.75 | $141K | -5.2% | -0.1% | -0.1% |
| CME | SELL · 10b5-1 | 2007-06-15 | 2007-06-19 | $551.50 | $331K | -5.2% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.